Schechter Investment Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,602
Closed -$202K 648
2024
Q4
$202K Buy
+2,602
New +$193K 0.02% 576
2024
Q3
Sell
-4,923
Closed -$558K 683
2024
Q2
$558K Buy
4,923
+687
+16% +$86.9K 0.04% 350
2024
Q1
$587K Buy
4,236
+46
+1% +$5.78K 0.04% 349
2023
Q4
$520K Sell
4,190
-618
-13% -$63.1K 0.05% 346
2023
Q3
$449K Sell
4,808
-994
-17% -$112K 0.04% 366
2023
Q2
$746K Sell
5,802
-862
-13% -$104K 0.07% 301
2023
Q1
$774K Buy
6,664
+907
+16% +$102K 0.07% 311
2022
Q4
$652K Buy
5,757
+2,046
+55% +$225K 0.06% 423
2022
Q3
$299K Sell
3,711
-1,791
-33% -$152K 0.03% 702
2022
Q2
$410K Sell
5,502
-738
-12% -$67.4K 0.04% 589
2022
Q1
$798K Sell
6,240
-392
-6% -$42.9K 0.07% 386
2021
Q4
$890K Buy
+6,632
New +$953K 0.08% 345

Other funds holding DXCM

Schechter Investment Advisors's DXCM Position: Q1 2025 in Review

Schechter Investment Advisors sold out of DexCom (DXCM) in Q1 2025, closing a stake of 2,602 shares — an estimated $202K sold.

Schechter Investment Advisors first reported a position in DXCM in Q4 2021 and held it in 12 quarters. The position peaked at $890K in Q4 2021. 932 funds tracked by Wall St. Rank hold DXCM as of Q1 2025.

  • Schechter Investment Advisors reported no remaining DexCom position as of Q1 2025 after selling out during the quarter.
  • Schechter Investment Advisors sold 2,602 DexCom shares in Q1 2025, an estimated $202K.
  • Schechter Investment Advisors first reported a position in DexCom in Q4 2021 and held it in 12 quarters.
  • Schechter Investment Advisors's DexCom position peaked at $890K in Q4 2021.
  • 932 funds tracked by Wall St. Rank held DexCom as of Q1 2025.

Based on Schechter Investment Advisors's 13F filing for Q1 2025, filed 1 May 2025.